Tradestie Institutional Equity Comparison Engine

PTN vs JAGX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTN Overall Edge

PTN Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palatin Technologies, Inc. (PTN) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, PTN trades at 42.9x Forward P/E with -65.7% operating margin (-80.1% YoY revenue) versus JAGX at N/M Forward P/E and -90.2% operating margin (-58.9% YoY). In options structure, PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against JAGX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PTN
PTN 42.9x vs JAGX N/M Fwd P/E
Growth & Margin Winner PTN
Op Margin -65.7% vs -90.2% ยท YoY -80.1% vs -58.9%
Momentum & Technical Winner PTN
1Y -43.3% vs -77.3% ยท 52W Pos 6% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0
JAGX NASDAQ
Jaguar Health, Inc.
Pharmaceutical Preparations
$0.39
-7.74% 1D
Market Cap $5.6M
1M Return -89.04%
1Y Return -77.27%
Forward P/E N/M
Unified AI Score
54.5 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTN -43.29% JAGX -77.27% Spread: +33.98 pp (PTN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PTN Revenue JAGX Revenue PTN Op. Margin JAGX Op. Margin Margin Edge
FY2019 $60M $10M 59.3% -501.3% PTN
FY2020 $0M $10M -20007.6% -283.9% JAGX
FY2021 N/A $0M N/A -939.1% JAGX
FY2022 $0M $10M -2491.6% -287.8% JAGX
FY2023 $0M $10M -668.7% -351.3% JAGX
FY2024 $0M $10M -501.0% -263.8% JAGX
FY2025 N/A $10M N/A -398.8% JAGX
FY2026 $10M N/A -65.7% N/A PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTN (6) vs JAGX (3)
Institutional Metric PTN JAGX Criterion Row Winner
Market Capitalization Scale $11.1M $5.6M Larger Scale Tie
Trailing P/E Ratio Valuation 42.9x N/M Lower Multiple PTN
Forward P/E Ratio Valuation 42.9x N/M Lower Multiple PTN
Revenue Growth (YoY) Growth -80.1% -58.9% Higher Growth JAGX
Operating Margin (TTM) Profitability -65.7% -90.2% Higher Margin PTN
Net Profit Margin Profitability -63.5% -130.8% Higher Margin PTN
Return on Equity (ROE) Capital Efficiency -877.5% -548.8% Higher ROE JAGX
52-Week Range Position Momentum 6% ($5โ€“$31) 0% ($0โ€“$42) Stronger Trend PTN
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 106% Vol 30.19ฮฒ ยท 228% Vol Lower Realized Risk PTN
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 54.5 / 100 (HOLD) Higher Composite JAGX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTN vs JAGX Buy Guide
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
JAGX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live JAGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTN nor JAGX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.